Office: 808A Salk Hall
Shilpa Sant, PhD is an Assistant Professor at University of Pittsburgh in the Departments of Pharmaceutical Sciences and Bioengineering. Before joining Pitt, she was a Ruth Kirschstein NRSA Interdisciplinary training fellow at the Wyss Institute for Biologically Inspired Engineering, Harvard University, and the Center for Bioengineering at Brigham and Women’s Hospital, Harvard Medical School in Boston, MA.
Dr. Sant received a PhD in Pharmaceutical Technology from University of Montreal, Canada, MS in Pharmacology and BS (BPharm) in Pharmaceutical Sciences from the University of Mumbai. She has extensive research experience in diverse fields including materials science, polymer chemistry, drug delivery, tissue engineering, natural and synthetic biomaterials and microfabrication.
Her postdoctoral research involved fabrication of functionalized bioinspired materials and scaffolds applicable for the heart valve and tooth germ tissue engineering. She has contributed over 40 articles in peer-reviewed journals, 5 book chapters, 8 conference abstracts, over 50 podia and over 70 poster presentations. She has also edited a book entitled “Nanomaterials in Tissue Engineering: Fabrication and Applications” and a journal issue “Stem Cells: Microenvironment, Micro/Nanotechnology, and Application”, in “Stem Cells International”.
Dr. Sant’s exemplary achievements in research have been recognized by prestigious fellowships: Ruth L. Kirschstein National Research Service Award (NIH, USA), Post-doctoral Fellowship (Le Fonds Quebecoise de Recherche sur Nature et Technologies (FQRNT), Canada), Post-graduate Scholarship B (Natural Sciences and Engineering Research Council of Canada (NSERC), Canada). She has also received several awards including “2016 CMBE-BMES Rising Star Early Career Faculty Award” “2013 CMBE-BMES Rising Star/Fellow Award”, “2010 Society For Biomaterials – STAR Award” to name a few. She serves as an Associate Editor for IEEE Transaction on NanoBioScience, editorial board member for Scientific Reports and In Silico pharmacology to name a few.
Dr. Sant's research goals are to develop an independent and multidisciplinary research program at the interface of biomaterials, controlled drug delivery, and tissue engineering. Specifically, she aims to develop tissue-engineered disease models that recreate the three-dimensional structure, cell-cell/cell-ECM interaction, stromal environments, and signalling cues present in vivo. Dr. Sant is a member of the Biomedical Engineering Society, Society for Biomaterials, American Association of Cancer Research, the Indian Pharmaceutical Association, and Sigma Xi.